
Go or no go? Big decisions loom for Bristol and Sanofi
The FDA will have a busy November, with decisions due for Bristol, Sanofi and Y-mabs, among others.
The FDA will have a busy November, with decisions due for Bristol, Sanofi and Y-mabs, among others.